Advertisement for orthosearch.org.uk
Results 1 - 12 of 12
Results per page:
Bone & Joint 360
Vol. 4, Issue 1 | Pages 28 - 29
1 Feb 2015

The February 2015 Oncology Roundup. 360 . looks at: Achieving global collaboration; A new standard for limb salvage; Inoperable chondrosarcoma and chemotherapy; Soft-tissue sarcoma and adjuvant chemotherapy; Missed diagnoses and malpractice in sarcoma; Radiofrequency and cartilage tumours


Bone & Joint 360
Vol. 4, Issue 6 | Pages 23 - 24
1 Dec 2015

The December 2015 Oncology Roundup. 360 . looks at: Amputation may not be the best option; Growing golf balls bad news!; How close is safe? Radiotherapy and surgery; Lymphocyte: monocyte ratio in osteosarcoma; Are borderline cartilage tumours really borderline?; Boosting algorithms improves survival estimates; CT better than Mirels?


The Bone & Joint Journal
Vol. 106-B, Issue 5 | Pages 425 - 429
1 May 2024
Jeys LM Thorkildsen J Kurisunkal V Puri A Ruggieri P Houdek MT Boyle RA Ebeid W Botello E Morris GV Laitinen MK

Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of the primary tumour, subtypes, and complications. Therefore, consensus on its day-to-day treatment decisions is needed. In January 2024, the Birmingham Orthopaedic Oncology Meeting (BOOM) attempted to gain global consensus from 300 delegates from over 50 countries. The meeting focused on these critical areas and aimed to generate consensus statements based on evidence amalgamation and expert opinion from diverse geographical regions. In parallel, periprosthetic joint infection (PJI) in oncological reconstructions poses unique challenges due to factors such as adjuvant treatments, large exposures, and the complexity of surgery. The meeting debated two-stage revisions, antibiotic prophylaxis, managing acute PJI in patients undergoing chemotherapy, and defining the best strategies for wound management and allograft reconstruction. The objectives of the meeting extended beyond resolving immediate controversies. It sought to foster global collaboration among specialists attending the meeting, and to encourage future research projects to address unsolved dilemmas. By highlighting areas of disagreement and promoting collaborative research endeavours, this initiative aims to enhance treatment standards and potentially improve outcomes for patients globally. This paper sets out some of the controversies and questions that were debated in the meeting.

Cite this article: Bone Joint J 2024;106-B(5):425–429.


Bone & Joint 360
Vol. 8, Issue 5 | Pages 35 - 37
1 Oct 2019


Bone & Joint 360
Vol. 8, Issue 4 | Pages 37 - 39
1 Aug 2019


Bone & Joint 360
Vol. 8, Issue 5 | Pages 4 - 10
1 Oct 2019
Tsoi K Samuel A Jeys LM Ashford RU Gregory JJ


Bone & Joint 360
Vol. 6, Issue 3 | Pages 30 - 31
1 Jun 2017


Bone & Joint 360
Vol. 6, Issue 6 | Pages 33 - 35
1 Dec 2017


Bone & Joint 360
Vol. 6, Issue 5 | Pages 30 - 33
1 Oct 2017


Bone & Joint 360
Vol. 5, Issue 5 | Pages 30 - 32
1 Oct 2016


Bone & Joint 360
Vol. 5, Issue 2 | Pages 28 - 31
1 Apr 2016


Bone & Joint 360
Vol. 2, Issue 4 | Pages 24 - 26
1 Aug 2013

The August 2013 Oncology Roundup360 looks at: spinal osteosarcoma: all hope is not lost; intralesional curettage for low-grade chondrosarcoma?; isolated limb perfusion is a salvage option; worryingly high infection rates in patients with endoprostheses; how bad is endoprosthetic infection?; operatively treated metastatic disease; and cementoplasty gives immediate pain relief